Microba Life Sciences Limited

ASX:MAP Stock Report

Market Cap: AU$82.9m

Microba Life Sciences Management

Management criteria checks 2/4

We currently do not have sufficient information about the CEO.

Key information

Luke Reid

Chief executive officer

AU$382.3k

Total compensation

CEO salary percentage72.6%
CEO tenure2.8yrs
CEO ownership0.06%
Management average tenureno data
Board average tenure1.5yrs

Recent management updates

Recent updates

We're Hopeful That Microba Life Sciences (ASX:MAP) Will Use Its Cash Wisely

Aug 01
We're Hopeful That Microba Life Sciences (ASX:MAP) Will Use Its Cash Wisely

We're Not Very Worried About Microba Life Sciences' (ASX:MAP) Cash Burn Rate

Apr 28
We're Not Very Worried About Microba Life Sciences' (ASX:MAP) Cash Burn Rate

Is Microba Life Sciences (ASX:MAP) In A Good Position To Invest In Growth?

Jul 05
Is Microba Life Sciences (ASX:MAP) In A Good Position To Invest In Growth?

CEO Compensation Analysis

How has Luke Reid's remuneration changed compared to Microba Life Sciences's earnings?
DateTotal CompensationSalaryCompany Earnings
Dec 31 2023n/an/a

-AU$18m

Sep 30 2023n/an/a

-AU$16m

Jun 30 2023AU$382kAU$278k

-AU$13m

Mar 31 2023n/an/a

-AU$12m

Dec 31 2022n/an/a

-AU$11m

Sep 30 2022n/an/a

-AU$11m

Jun 30 2022AU$407kAU$248k

-AU$11m

Mar 31 2022n/an/a

-AU$11m

Dec 31 2021n/an/a

-AU$11m

Sep 30 2021n/an/a

-AU$9m

Jun 30 2021AU$268kAU$144k

-AU$8m

Compensation vs Market: Luke's total compensation ($USD249.81K) is about average for companies of similar size in the Australian market ($USD292.20K).

Compensation vs Earnings: Luke's compensation has been consistent with company performance over the past year.

CEO

Luke Reid

2.8yrs

Tenure

AU$382,284

Compensation

Dr. Luke Reid is Chief Executive Officer of Microba Life Sciences Limited from July 15, 2021. He is an experienced research and technology commercialisation executive. His deep knowledge of the biotechnolo...

Board Members

NamePositionTenureCompensationOwnership
Gene Tyson
Co-Founder & Non-Executive Directorno dataAU$120.79k3.82%
A$ 3.2m
Philip Hugenholtz
Co-Founder & Chair of Scientific Advisory Boardno datano datano data
Pasquale Rombola
Independent Non-Executive Chairmanno dataAU$111.69k1.29%
A$ 1.1m
Ian Frazer
Independent Non-Executive Deputy Chairman of the Board & Chair of Medical Advisory Boardno dataAU$106.69k0.37%
A$ 302.5k
Jacqueline Fernley
Independent Non-Executive Director1.7yrsAU$40.83kno data
Stephen Fairy
Member of Medical Advisory Board1.5yrsno datano data
Richard Bund
Non-Executive Directorno dataAU$77.79k7.48%
A$ 6.2m
Hyungtae Kim
Non-Executive Directorno dataAU$67.79kno data
Paul Griffin
Member of Medical Advisory Boardno datano datano data
Jake Begun
Member of Medical Advisory Boardno datano datano data
Chris Hogan
Member of Medical Advisory Board1.5yrsno datano data

1.5yrs

Average Tenure

Experienced Board: MAP's board of directors are not considered experienced ( 1.5 years average tenure), which suggests a new board.

Simply Wall St™
Simply Wall Street Pty Ltd
Level 7, 320 Pitt Street, Sydney
Download on the App StoreGet it on Google Play
Popular Markets
USAUUKINCAZA
About UsCareersPlansLogin
Help CenterLatest CoveragePodcastsAffiliate ProgramBusiness & Enterprise
Financial Services GuideTerms and ConditionsPrivacy PolicyLogos provided by Clearbit
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.